摘要
目前还没有针对由严重急性呼吸综合征冠状病毒2型引起的新型冠状病毒肺炎的特效药物或治疗方法。本文通过研究新型冠状病毒肺炎、肠道菌群及免疫系统之间的关系及肠道菌群影响新型冠状病毒肺炎的相关机制,探究粪菌移植在新型冠状病毒肺炎治疗中的应用前景,以期为治疗新型冠状病毒肺炎提供新的方法。
There is no specific drug or treatment for COVID-19 caused by SARSCoV-2 currently.In this paper,by studying the relationship between COVID-19,intestinal flora,and immune system,and the related mechanism of intestinal flora affecting COVID-19,fecal microbiota transplantation in the treatment of COVID-19 is explored so as to provide new methods for the treatment of COVID-19.
作者
顾家博
孟君
常有
金黑鹰
刘建磊
Gu Jiabo;Meng Jun;Chang You;Jin Heiying;Liu Jianlei(Lianyungang Hospital of Traditional Chinese Medicine,Lianyungang 222004,China;Nanjing University of Chinese Medicine,Nanjing 210029,China;Jiangsu Provincial Second Chinese Medicine Hospital,Nanjing 210017,China)
出处
《国际医药卫生导报》
2023年第6期745-749,共5页
International Medicine and Health Guidance News
基金
江苏省中医药管理局面上项目(MS2021030)。
关键词
粪菌移植
新型冠状病毒肺炎
肠道菌群
Fecal microbiota transplantation
COVID-19
Intestinal flora
